Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing report Order by Fax Printer Friendly Send to Friend Enquire before Buying Electronic (PDF)   Enterprisewide   Chugai Pharmaceutical Co., Ltd. - SWOT Analysis Datamonitor, May 2009, Pages: 24   Description     Table of Contents        Enquire before Buying    Send to a Friend   The Chugai Pharmaceutical Co., Ltd. - SWOT Analysis company profile is the essential source for top-level company data and information. Chugai Pharmaceutical Co., Ltd. - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Chugai Pharmaceutical (Chugai), a subsidiary of the Roche Group, is engaged in biopharmaceutical research and development. It produces antibody drugs, focused in the three areas, oncology, renal diseases and bone and joint diseases. The company primarily operates in Europe, Americas and Asia Pacific. It is headquartered in Tokyo, Japan and employed 6,383 people as of December 2008. The company recorded revenues of JPY326,938 million (approximately $3,171.3 million-) during the financial year (FY) ended December 2008, a decrease of 5.2% over FY2007. The decrease was mainly due to the significant drop in Epogin sales when compared with that of previous year. The operating profit of the company was JPY51,563 million (approximately $500.2 million-) during FY2008, a decrease of 22.7% over FY2007. The net profit was JPY39,265 million (approximately $380.9 million-) in FY2008, a decrease of 2% over FY2007. -Calculated using the constant conversion rate of JPY1 = $0.0097 for the year ended December 2008. Scope of the Report - Provides all the crucial information on Chugai Pharmaceutical Co., Ltd. required for business and competitor intelligence needs - Contains a study of the major internal and external factors affecting Chugai Pharmaceutical Co., Ltd. in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Chugai Pharmaceutical Co., Ltd. -Data is supplemented with details on Chugai Pharmaceutical Co., Ltd. history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Chugai Pharmaceutical Co., Ltd. Reasons to Purchase - Support sales activities by understanding your customers’ businesses better - Qualify prospective partners and suppliers - Keep fully up to date on your competitors’ business structure, strategy and prospects - Obtain the most up to date company information available

		Top of page

All rights reserved. ? Copyright 2010 Research and Markets0    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster